RxDoctor Payments Data

Luis Sanchez-Erebia, PA

Physician Assistant · Jackson, MINPI 1043872740

Payments from drug & device makers

$3,859in general payments, 2019–2025

Across 60 payments — averaging $64.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$1K
  • Boston Scientific$771
  • Johnson & Johnson$377
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$278
  • E.r. Squibb & Sons, L.L.C.$256
  • AstraZeneca$250
  • plus $717 from 8 others

What the payments were for

  • Travel & lodging$61216%
  • Food & beverage$3,10881%
  • Education$1404%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,859 in reported general payments places this provider in the 90th percentile of 5,453 physician assistant providers in Michigan.

See all physician assistant providers in Michigan

Medicare billing

Part B allowed, 2024
$35,266
Medicare patients
308
Services billed
558

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban231$201,041
EntrestoSacubitril/Valsartan30$30,365
XareltoRivaroxaban29$26,965
JardianceEmpagliflozin24$16,284
Metoprolol Succinate192$3,018
Rosuvastatin Calcium72$1,182
Carvedilol70$868
Isosorbide Mononitrate ErIsosorbide Mononitrate52$830
Atorvastatin Calcium51$821
Diltiazem 24hr Er (Cd)Diltiazem Hcl25$721
Losartan Potassium73$689
Flecainide Acetate30$652
Ezetimibe24$639
SotalolSotalol Hcl20$374
Nitroglycerin37$330

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$132$201,041231 claims
Johnson & JohnsonXarelto$377$26,96529 claims
Boehringer IngelheimJardiance$140$16,28424 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 5,453 physician assistant providers in Michigan.

Other physician assistant in Jackson

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →